Evidence map›Paper›PMID 26563446›Full record

ArticleContemporary clinical trials2016

Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study.

Li-Tzy Wu, Kathleen T Brady, Susan E Spratt, Ashley A Dunham, Brooke Heidenfelder, Bryan C Batch, Robert Lindblad, Paul VanVeldhuisen, Shelley A Rusincovitch, Therese K Killeen and 1 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Contemporary clinical trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01966432 (Screening, Brief Intervention, and Referral to Treatment in Primary Care), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01966432 nacompletednot on this map

Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC): An add-on Project to "Duke University Southeastern Diabetes Initiative"

TypeinterventionalSponsorDuke UniversityRan2013 to 2016Enrolled134ConditionsDiabetes Mellitus, Type 2, Substance-related DisordersArmsReferral to Treatment, Brief Intervention
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Li-Tzy WuDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: Litzy.wu@duke.edu.
Kathleen T BradySouth Carolina Clinical and Translational Research Institute, Medical University of South Carolina, Charleston, SC, USA.
Susan E SprattDivision of Endocrinology, Duke University Medical Center, Durham, NC, USA.
Ashley A DunhamDuke Translational Research Institute, Duke University Medical Center, Durham, NC, USA.
Brooke HeidenfelderDuke Translational Research Institute, Duke University Medical Center, Durham, NC, USA.
Bryan C BatchDivision of Endocrinology, Duke University Medical Center, Durham, NC, USA.
Robert LindbladThe EMMES Corporation, Rockville, MD, USA.
Paul VanVeldhuisenThe EMMES Corporation, Rockville, MD, USA.
Shelley A RusincovitchDuke Translational Research Institute, Duke University Medical Center, Durham, NC, USA.
Therese K KilleenDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA.
Udi E GhitzaNational Institute on Drug Abuse, Bethesda, MD, USA.
Duke Medical Center · USEmmes (United States) · USMedical University of South Carolina · USDuke University Hospital · USNational Institute on Drug Abuse · US

Funding

Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
Project-003UG1DA040317 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2015 to 2019
$9.0M
Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race IndR01MD007658 · NIMHD · DUKE UNIVERSITY · PI WU, LI-TZY · 2013 to 2017
$1.8M
Opioid Dependence, Immunity and InfectionR01DA014223 · NIDA · TEMPLE UNIVERSITY · PI EISENSTEIN, TOBY K. · 2001 to 2005
$1.7M
MDMA and Other Hallucinogen Use: Onset and Abuse/DependenceR01DA019623 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2013
$1.1M
Classification of Substance Use Severity and Treatment Outcomes: NIDA CTN StudiesR33DA027503 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2010 to 2012
$1.1M
Epdemiology of Non-Medical Prescription Anagesic UseR01DA019901 · NIDA · DUKE UNIVERSITY · PI WU, LI-TZY · 2007 to 2009
$416k
NIDA NIH HHS HHSN271200522071CNIDA NIH HHS HHSN271201200017CNIDA NIH HHS HHSN271201400028CNIDA NIH HHS N01DA-12-2229NIDA NIH HHS N01DA-14-223NIDA NIH HHS R01 DA019623NIDA NIH HHS R01DA019623NIDA NIH HHS R01 DA019901NIDA NIH HHS R01DA019901NIDA NIH HHS R33 DA027503NIDA NIH HHS R33DA027503NIDA NIH HHS U10 DA013727NIDA NIH HHS U10DA013727NIDA NIH HHS UG1 DA040317NIDA NIH HHS UG1DA040317NIMHD NIH HHS R01 MD007658NIMHD NIH HHS R01MD007658PHS HHS HHSN271200522071CPHS HHS HHSN271201200017CPHS HHS HHSN271201400028C
6 · The paper itself

Abstract

backgroundThe Affordable Care Act encourages healthcare systems to integrate behavioral and medical healthcare, as well as to employ electronic health records (EHRs) for health information exchange and quality improvement. Pragmatic research paradigms that employ EHRs in research are needed to produce clinical evidence in real-world medical settings for informing learning healthcare systems. Adults with comorbid diabetes and substance use disorders (SUDs) tend to use costly inpatient treatments; however, there is a lack of empirical data on implementing behavioral healthcare to reduce health risk in adults with high-risk diabetes. Given the complexity of high-risk patients' medical problems and the cost of conducting randomized trials, a feasibility project is warranted to guide practical study designs.

methodsWe describe the study design, which explores the feasibility of implementing substance use Screening, Brief Intervention, and Referral to Treatment (SBIRT) among adults with high-risk type 2 diabetes mellitus (T2DM) within a home-based primary care setting. Our study includes the development of an integrated EHR datamart to identify eligible patients and collect diabetes healthcare data, and the use of a geographic health information system to understand the social context in patients' communities. Analysis will examine recruitment, proportion of patients receiving brief intervention and/or referrals, substance use, SUD treatment use, diabetes outcomes, and retention. DISCUSSION: By capitalizing on an existing T2DM project that uses home-based primary care, our study results will provide timely clinical information to inform the designs and implementation of future SBIRT studies among adults with multiple medical conditions.

Indexed as

Electronic Health RecordsPrimary Health CareComorbidityDiabetes Mellitus, Type 2Feasibility StudiesHumansMass ScreeningNorth CarolinaPatient Protection and Affordable Care ActProspective StudiesReferral and ConsultationSubstance-Related DisordersDiabetesHome-based primary careMedical comorbidityReferral to treatmentSubstance use disorderSubstance use screening

Identifiers

PMID26563446
PMCPMC4695300
OpenAlexW2169921084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.